Anivive Lifesciences INC.

Biotechnology research company developing novel therapeutics to reshape pet healthcare.

Based in CA

🤖

AI Overview

With $110K in lobbying spend across 6 quarterly filings, Anivive Lifesciences INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2023 to 2024.

$110K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$80K
2024$30K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

  • H.R.6227 - Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023; S.3220 - A bill to expand the tropical disease product priority review voucher program to encourage prevent
  • Issues related to Valley fever; H.R. 6227/S.3220 - Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023; H.R. 6731/S.3464, the FORWARD Act.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.